Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHA:605016)

SHA:605016 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,225	1,107	854.14	696.18	638.52	491.11
Other Revenue	45	45	14.12	25.71	14.83	8.52
Revenue	1,270	1,152	868.26	721.89	653.36	499.62
Revenue Growth (YoY)	28.70%	32.64%	20.28%	10.49%	30.77%	18.66%
Cost of Revenue	818.38	764.89	584.2	493.41	471.72	336.39
Gross Profit	451.69	386.76	284.06	228.49	181.64	163.23
Selling, General & Admin	67.54	67.54	47.77	45.05	40.35	32.44
Research & Development	44.46	44.46	32.56	27.03	23.26	15.37
Other Operating Expenses	9.68	9.68	7.61	5.99	5.67	6.03
Operating Expenses	127.92	127.92	90.61	82.81	71.65	55.79
Operating Income	323.77	258.84	193.45	145.68	109.98	107.44
Interest Expense	-2.66	-2.66	-2.25	-0.07	-1.04	-4.21
Interest & Investment Income	9.61	9.61	12.14	12.76	5.04	3.2
Currency Exchange Gain (Loss)	8.17	8.17	4.13	10.28	-2.76	-4.09
Other Non Operating Income (Expenses)	-0.88	-0.43	-0.21	-0.13	-0.14	-0.23
EBT Excluding Unusual Items	338.02	273.53	207.27	168.52	111.09	102.11
Gain (Loss) on Sale of Investments	1.27	1.27	2.7	0	3.35	-
Gain (Loss) on Sale of Assets	-0.39	-0.39	-2.13	-3.15	-1.26	-0.88
Asset Writedown	-	-	-	-	-1.73	-
Other Unusual Items	10.89	10.89	13.68	7.71	7.32	8.86
Pretax Income	349.79	285.31	221.52	173.09	118.77	110.09
Income Tax Expense	53.17	39.71	28.52	22.34	14.29	14.54
Net Income	296.63	245.6	193	150.75	104.48	95.55
Net Income to Common	296.63	245.6	193	150.75	104.48	95.55
Net Income Growth	33.94%	27.26%	28.02%	44.29%	9.34%	15.43%
Shares Outstanding (Basic)	418	420	418	418	385	313
Shares Outstanding (Diluted)	418	420	418	418	385	313
Shares Change (YoY)	-0.49%	0.46%	0.12%	8.63%	22.70%	-0.59%
EPS (Basic)	0.71	0.58	0.46	0.36	0.27	0.30
EPS (Diluted)	0.71	0.58	0.46	0.36	0.27	0.30
EPS Growth	34.60%	26.67%	27.88%	32.83%	-10.89%	16.11%
Free Cash Flow	-	19.09	-117.34	-25.78	40.38	37.37
Free Cash Flow Per Share	-	0.04	-0.28	-0.06	0.10	0.12
Dividend Per Share	0.123	0.146	0.142	0.072	0.026	-
Dividend Growth	-25.44%	2.96%	97.50%	180.86%	-	-
Gross Margin	35.56%	33.58%	32.72%	31.65%	27.80%	32.67%
Operating Margin	25.49%	22.48%	22.28%	20.18%	16.83%	21.50%
Profit Margin	23.36%	21.33%	22.23%	20.88%	15.99%	19.13%
Free Cash Flow Margin	-	1.66%	-13.51%	-3.57%	6.18%	7.48%
EBITDA	413.1	334.22	238.38	192.42	156.51	150.38
EBITDA Margin	32.53%	29.02%	27.46%	26.66%	23.96%	30.10%
D&A For EBITDA	89.32	75.38	44.93	46.75	46.53	42.94
EBIT	323.77	258.84	193.45	145.68	109.98	107.44
EBIT Margin	25.49%	22.48%	22.28%	20.18%	16.83%	21.50%
Effective Tax Rate	15.20%	13.92%	12.88%	12.91%	12.04%	13.21%
Revenue as Reported	1,152	1,152	868.26	721.89	653.36	-
Advertising Expenses	-	3.48	2.9	1.13	1.25	0.53

Updated Feb 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.